Agilents GeneSpring Bioinformatics Option integrated with GeneGos MetaCore GeneGo.
Agilent’s GeneSpring Bioinformatics Option integrated with GeneGo’s MetaCore GeneGo, Inc., a respected provider of databases, software program and services in systems biology and chemistry, and Agilent Technologies, Inc., the world’s premier measurement firm and a technology leader in chemical analysis, existence sciences, communications and electronics, announced today that they have integrated Agilent’s GeneSpring Bioinformatics Solution with MetaCore online drugstore .5, today released, introduces a multi-omics mass-spectrometry and microarray based evaluation suite to take care of transcriptomics, genomics, metabolomics and proteomics data in one application. GeneSpring GX 11.5 carries a direct link with the MetaCore pathway analysis engine that allows users to seamlessly upload expression data analyzed in GeneSpring for pathway analysis in MetaCore.
For an older individual with a poor prognosis and high risk for metastatic disease, an intense protocol may have the advantages of detecting metastases previously and allowing initiation of treatment or enrollment in cure trial sooner, which may outweigh the dangers, McCannel et al say. Licensed from medwireNews with authorization from Springer Health care Ltd. All privileges reserved. Neither of the parties endorse or recommend any commercial products, services, or equipment.. Aggressive surveillance questionable for vision melanoma recurrence By Lynda Williams, Senior medwireNews Reporter Sufferers treated for primary choroidal or ciliary body melanoma may not always reap the benefits of an aggressive surveillance strategy for the recognition of metastatic disease, caution US researchers.